Acumen Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.85-$3.05 |
Market Cap | $168.3M |
Shares Short | 947,292 |
Financials
See moreRevenue (12 Mos) | $329,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$118.9M |
Diluted EPS | -$2.21 |
News
See moreYahoo Finance • 3 months ago
Healthcare Names Post Strong After-Hours Moves: KYMR, OCUL, POAI Among Top Gainers
Yahoo Finance • 3 months ago
Acumen Pharmaceuticals And 2 Other Penny Stocks Worth Watching
Yahoo Finance • 6 months ago
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance • 7 months ago
Acumen Pharmaceuticals stock maintains Buy rating at BTIG on promising Alzheimer's drug
About
CEO | Mr. Daniel J. O'Connell M.B.A. |
CFO | Mr. Matt Zuga |
Address | 1210-1220 Washington St., Newton, MA, United States, 02465 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
